Professor Sanjay Garg

Professor of Pharmaceutical Science School of Pharmacy and Medical Sciences

City West Campus (HB5-26A)
tel +61 8 830 21575

email Sanjay.Garg@unisa.edu.au

Alternative contact

Available for media comment
Research Degree Supervisor

About me

Cancer
Antimicrobials
Pharmaceutics and Nanotechnology
Advanced drug delivery
Animal health

Your Partner in Translational Pharmaceutical Research: from Molecules to Medicines

Professor Sanjay Garg is the Director of the Centre for Pharmaceutical Innovation and Development (CPID). He is a pharmaceutical scientist with a passion for research and teaching in translational drug development and delivery, with a mission to make lives better for our patients. His interdisciplinary research is based on the principles of innovation, engagement, translation and quality.

School of Pharmacy and Medical Sciences

With standout facilities and strong industry links, the School prepares students for careers in health and medical science.

Other UniSA associations

Tweets by @UniversitySA

About me

Your Partner in Translational Pharmaceutical Research: from Molecules to Medicines

Prof Garg's team is focusing on novel anticancer drug delivery systems, nanotechnology, antibacterial compounds and formulations for superbugs, wound healing, and veterinary formulations. With the research team, Prof Garg has published 181 peer-reviewed papers, 37 patents, 24 book chapters, edited four books, and successfully completed technology transfers for ten products, leading to h index of 47 (Google Scholar). He has supervised 201 research scholars at all levels, including 7 current PhD students.

For cancer drug targeting, his team is exploring both local as well as systemic delivery approaches. PhD Scholars Paris and Arafat are developing oesophageal and colonic stents as the vehicles for delivering single and the combination of anticancer drugs to control GI tumour growth, manage obstructions and alleviate dysphagia while minimizing systemic side effects. To achieve site-specific targeting, Franklin is using novel drug loaded responsive hydrogel to treat colon cancer. Candace is exploiting the properties of nano-silica materials to actively deliver anticancer agents to breast tumours. She is functionalizing drug-loaded nanoparticles with targeting ligands, using a bioconjugate and a pH-sensitive component to achieve drug release in the breast cancer microenvironment.

Prof Garg has a strong track record of working with the development of novel antimicrobial compounds and formulations for human and veterinary applications. In highly successful partnership with Prof Darren Trott from the Australian Centre for Antimicrobial Resistance Ecology (ACARE) University of Adelaide, Prof Adam McCluskey (University of Newcastle), Dr Stephen Page (Luoda Pharma and Neoculi Ltd), Dr Sam Abraham (Murdoch University) and alongside others, he is leading the preclinical development of new drug candidates with activity against resistant pathogens. Recent patents (US9775818 and US 9539223) on methods for treating bacterial infections cover the output from these efforts. Netra, an honours student is using pharmaceutical approaches to improve antimicrobial activity and reduce the toxicity of selected compounds. In collaboration with Prof Allison Cowin and Prof Krasi Vasilev (Future Industries Institute), PhD students Pivian and Hanif are assessing the role of pH in wound healing and developing new therapeutics for wound repair using nano-technological approaches.

Working on collaborative and sponsored projects with several companies, his team is rapidly developing expertise in veterinary delivery systems for cattle, horses, pigs, cats, dogs, and fish. An innovative injectable IM formulation of highly unstable drug Omeprazole is revolutionizing the treatment of equine gastric ulcer. The preparation is in the process of registration with the USA and European agencies. Formulations for antimicrobial compounds have gone through clinical evaluation in mastitis in cows. The application of lessons learned from human pharmaceuticals to veterinary preparations is helping in finding new ways of delivering drugs to animals in swine farms and aquaculture, not only improving the health and well-being of the animals but the safety and quality of products for human consumption.

He continues to work on projects that benefit patients directly and are at the crossroads of pharmacy practice and science, e.g. extemporaneous compounding and analysis of drugs in human milk.

CPID laboratories are well equipped with laboratory and pilot scale pharmaceutical development, analysis and characterization equipment for various dosage forms, including tabletting, extruder/spheronizer, encapsulation, spray and fluidized bed coating, stability chambers compliant to ICH guidelines, dissolution, Franz diffusion cells, texture analyser, HPLCs with PDA, fluorescence and ELSD detectors, LC-MS, NMR etc.

Prof Garg collaborates with several human and animal pharmaceutical, biotechnological, nutrition, and complementary medicine companies through private and partnership grants. His research has been supported by Govt. agencies, Foundations and Pharmaceutical companies (e.g. Australian Research Council (ARC), National Health and Medical Research Council (NHMRC), Tertiary Education Commission (TEC) New Zealand, Contraception Research and Development Program (CONRAD), USA; International Partnership for Microbicides (IPM), USA, and many others. He regularly reviews grants from ARC, NHMRC, and for National agencies from Brazil, UK, Singapore, Ireland, South Africa, and Hongkong.

He is passionate about International engagement and acts as Co-Director of the China-Australia Centre for Health Science Research (CACHSR), in collaboration with Shandong University, China. Prof Garg has ongoing adjunct appointments with the International Medical University (IMU), Malaysia and Manipal University, India. His research collaborations extend to USA, Canada, Brazil, India, Malaysia, and China, and he is very keen to develop new links, especially research staff and students exchanges for the short or long term.

After PhD from National Institute of Immunology, India, Prof Garg joined the Program for Topical Prevention of Conception and Disease (TOPCAD) Rush University, Chicago (1995-1998) USA, developing novel microbicides compounds and formulations. A number of his patented formulations have reached clinical stages and market in USA, India, New Zealand, Australia and U.K., e.g. Acidform, an acid-buffering formulation (USA Patent 6706276) has been approved by US FDA as a vaginal lubricant and completed Phase III trials (Amphora) as a contraceptive. During the tenure with the School of Pharmacy, the University of Auckland, New Zealand (2003-2011), he established AnQual Good Laboratory Practice (GLP) compliant analytical laboratory. Acting as Deputy Head of the Auckland Pharmacy School, he played a critical role in establishing research and post-graduate program.

In 2015, Prof Garg was honoured with Australasian Pharmaceutical Science Association (APSA) Medal. Some other awards that he has received include Butland Award for Excellence in Research Supervision, Young Pharmacy Teacher of the Year, and Fellowship of the Indian Pharmaceutical Association.

Research

Research themes

Transforming industries
Cancer
Healthy futures

Research focus

Pharmacology and Pharmaceutical Sciences
Analytical Chemistry
Public Health and Health Services
Clinical Sciences
Pharmacology and Pharmacy

Highlights

Anticancer drug delivery and nanomedicine: Local and systemic tumor targeting, applications of nanoscience to drug development.
Infections, microbicides (MPT) and contraception: Novel antibacterial compounds and formulations for resistant pathogens (Superbugs) in human and veterinary applications; vaginal multipurpose prevention technologies (MPT) for contraception, HIV and STIs.
Translational drug development and delivery: Preformulation, physico-chemical characterization, solubility and stability assessment and improvement, patentable non-infringing platform technologies: nanotechnology, solid, semisolid and liquid dosage forms; reverse engineering, cosmetics and complementary medicines.
Novel veterinary delivery systems: for... Read more

Research

Projects

Excludes commercial-in-confidence projects.

Drug targeting to immune cells using modified inulin particles, ARC - Linkage Project, 05/05/2015 - 07/11/2018
Pharmaceutical product development of a range of new compounds and existing drugs for human and veterinary applications, Luoda Pharma Pty Ltd, 06/04/2015 - 06/04/2018
Pharmaceutical Development of a novel carbohydrate compound, Sirtex Technologies Pty Ltd, 20/11/2015 - 30/09/2016
Development of novel vaginal microbicide tablets for an anti-HIV compound DS003, International Partnership for Microbicides, Inc., 15/08/2013 - 30/03/2016
Stability evaluation of extemporaneously compounded tacrolimus formulation, Pharmac, 25/09/2013 - 28/05/2015
SAXS and XRD characterisation of docetaxal containing polymeric films, Research Projects (Formerly AINSE Awards and Research Fellowships), 01/08/2014 - 15/03/2015
Development of novel antimicrobial compounds and formulations, Luoda Pharma Pty Ltd, 01/03/2013 - 01/03/2015
Establishing the evidence to ensure quality, safety, and effectiveness of the extemporaneously compounded formulations, Women's and Children's Hospital Foundation, 01/01/2013 - 01/07/2014
Penicillin antibiotic drug stability in syringes for the purposes of skin testing in drug allergy, Women's and Children's Hospital Foundation, 01/01/2013 - 01/07/2014
Scientific Collaboration in Development of Novel Multi-prevention Technologies for HIV/AIDS, Sexually Transmitted Infections and Conception, Australia-India Strategic Research Fund, 02/03/2013 - 17/03/2013
Development of tablet and capsule formulations for a pollution testing kit, CRC for Contamination Assessment and Remediation of the Environment, 08/10/2012 - 15/02/2013

Research

Outputs

Research since 2008 is shown below. To see earlier years visit ORCID, ResearcherID or Scopus

Open access indicates that an output is open access.

Highlights

Year	Output
2018	Zhang, W, Song, Y, Eldi, P, Guo, X, Hayball, JD, Garg, S & Albrecht, H 2018, 'Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles', International journal of nanomedicine, vol. 13, pp. 293-305. Open access 1 2
2017	Ogunniyi, AD, Khazandi, M, Stevens, AJ, Sims, SK, Page, SW, Garg, S, Venter, H, Powell, A, White, K, Petrovski, KR, Laven-Law, G, Tótoli, EG, Salgado, HR, Pi, H, Coombs, GW, Shinabarger, DL, Turnidge, JD, Paton, JC, McCluskey, A & Trott, DJ 2017, 'Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent', PLoS one, vol. 12, no. 9, article no. e0183457, pp. 1-23. Open access 2
2017	Zhang, B, Song, Y, Wang, T, Yang, S, Zhang, J, Liu, Y, Zhang, N & Garg, S 2017, 'Efficient co-delivery of immiscible hydrophilic/hydrophobic chemotherapeutics by lipid emulsions for improved treatment of cancer', International Journal of Nanomedicine, vol. 12, pp. 2871-2886. Open access 1 1
2016	Shaikh, M, Choudhury, NR, Knott, R, Kanwar, JR & Garg, S 2016, 'Effect of polymer microstructure on the docetaxel release and stability of polyurethane formulation', European Journal of Pharmaceutics and Biopharmaceutics, vol. 101, pp. 82-89. Open access 1 1
2016	Zhang, W, Garg, S, Eldi, P, Zhou, FH-h, Johnson, IR, Brooks, DA, Lam, F, Rychkov, G, Hayball, JD & Albrecht, H 2016, 'Targeting prostate cancer cells with genetically engineered polypeptide-based micelles displaying gastrin-releasing peptide', International journal of pharmaceutics, vol. 513, pp.270-279. 9 6 1

Books

Year	Output
2010	Garg, S 2010, MCQs in Pharmaceutical Science and Technology, Pharmaceutical Press.

Chapters

Year	Output
2013	Sharma, M, Svirskis, D & Garg, S 2013, 'Advances in drug-delivery systems based on intrinsically conducting polymers', in C Alverez-Lorenzo & A Concheiro (eds), RSC Smart Materials for Drug Delivery: volume 1, RSC Publishing, US, ch. 11, pp. 283-303. 5 3
2010	Sharma, P, Ganta, S & Garg, S 2010, 'Scale-Up and Postapproval Changes (SUPAC) Regulations', Pharmaceutical Manufacturing: Regulations and Quality, John Wiley & Sons Ltd, US, ch. 1.3, pp. 67-95. 3
2008	Ganta, S, Sharma, P & Garg, S 2008, 'Permeability assessment', Preclinical Development Handbook: ADME and Biopharmaceutical Properties (Pharmaceutical Development Series), John Wiley & Sons Ltd, USA, pp. 227-248.

Journal Articles

Year	Output
2018	Aithal, GC, Nayak, UY, Mehta, C, Narayan, R, Gopalkrishna, P, Pandiyan, S & Garg, S 2018, 'Localized in situ nanoemulgel drug delivery system of quercetin for periodontitis: development and computational simulations', Molecules, vol. 23, no. 6, pp. 1-15. Open access
2018	Garcia, J, Garg, A, Song, Y, Fotios, A, Andersen, C & Garg, S 2018, 'Compatibility of intravenous ibuprofen with lipids and parenteral nutrition, for use as a continuous infusion', PLoS one, vol. 13, no. 1, article no. e0190577, pp. 1-13. Open access 6
2018	Hickey, EE, Wong, HS, Khazandi, M, Ogunniyi, AD, Petrovski, KR, Garg, S, Page, SW, O'Handley, R & Trott, DJ 2018, 'Repurposing Ionophores as novel antimicrobial agents for the treatment of bovine mastitis caused by Gram-positive pathogens', Journal of veterinary pharmacology and therapeutics, vol. 41, no. 5, pp. 746-754.
2018	Kosari, S, Walker, E, Anderson, C, Peterson, G, Naunton, M, Castillo Martinez, E, Garg, S & Thomas, J 2018, 'Power outages and refrigerated medicines: The need for better guidelines, awareness and planning', Journal of clinical pharmacy and therapeutics, vol. 43, no. 5, pp. 737-739.
2018	Lwin, EMP, Gerber, C, Leggett, C, Song, Y, Ritchie, U, Turner, S, Hague, W, Upton, R & Garg, S 2018, 'Estimation of atenolol transfer into milk and infant exposure during Its ise in lactating women', Journal of human lactation, online, pp. 1-8.
2018	Mahendran, VJ, Stringer, AM, Semple, SJ, Song, Y & Garg, S 2018, 'Advances in the use of anti-inflammatory agents to manage chemotherapy-induced oral and gastrointestinal mucositis', Current pharmaceutical design, vol. 24, no. 14, pp. 1518-1532. 1
2018	Narayan, R, Nayak, UY, Raichur, AM & Garg, S 2018, 'Mesoporous silica nanoparticles: a comprehensive review on synthesis and recent advances', Pharmaceutics, vol. 10, no. 3, article no. 118, pp. 1-49. Open access
2018	Ogunniyi, AD, Kopecki, Z, Hickey, EE, Khazandi, M, Peel, E, Belov, K, Boileau, A, Garg, S, Venter, H, Chan, WY, Hill, PB, Page, SW, Cowin, AJ & Trott, DJ 2018, 'Bioluminescent murine models of bacterial sepsis and scald wound infections for antimicrobial efficacy testing', PLoS one, vol. 13, no. 7, article no. e0200195, pp. 1-13. Open access
2018	Parikh, A, Kathawala, K, Li, J, Chen, C, Shan, Z, Cao, X, Wang, Y-J, Garg, S & Zhou, X-f 2018, 'Self-nanomicellizing solid dispersion of edaravone: part II: in vivo assessment of efficacy against behavior deficits and safety in Alzheimer's disease model', Drug design development and therapy, vol. 12, pp. 2111-2128. Open access
2018	Parikh, A, Kathawala, K, Li, J, Chen, C, Shan, Z, Cao, X, Zhou, X-F & Garg, S 2018, 'Curcumin-loaded self-nanomicellizing solid dispersion system: part II: in vivo safety and efficacy assessment against behavior deficit in Alzheimer disease', Drug delivery and translational research, vol. 8, no. 5, pp. 1406-1420.
2018	Parikh, A, Kathawala, K, Song, Y, Zhou, XF & Garg, S 2018, 'Curcumin-loaded self-nanomicellizing solid dispersion system: part I: development, optimization, characterization, and oral bioavailability', Drug delivery and translational research, vol. 8, no. 5, pp. 1389-1405. 1
2018	Parikh, A, Kathawala, K, Tan, CC, Garg, S & Zhou, X-F 2018, 'Self-nanomicellizing solid dispersion of edaravone: part I - oral bioavailability improvement', Drug design development and therapy, vol. 12, pp. 2051-2069. Open access
2018	Song, Y, Whey Chin, Z, Ellis, D, Lwin, EMP, Turner, S, Williams, D & Garg, S 2018, 'Stability of an extemporaneously compounded minoxidil oral suspension', American journal of health-system pharmacy, vol. 75, no. 5, pp. 309-315. Open access 5
2018	Zhang, W, Song, Y, Eldi, P, Guo, X, Hayball, JD, Garg, S & Albrecht, H 2018, 'Targeting prostate cancer cells with hybrid elastin-like polypeptide/liposome nanoparticles', International journal of nanomedicine, vol. 13, pp. 293-305. Open access 1 2
2017	Haidari, H, Zhang, Q, Melville, E, Kopecki, Z, Song, Y, Cowin, AJ & Garg, S 2017, 'Development of topical delivery systems for flightless neutralizing antibody', Journal of pharmaceutical sciences, vol. 106, no. 7, pp. 1795-1804. Open access 1
2017	Knight, EC, Trott, DJ, Page, SW, Garg, S, Zhang, Q, Song, Y, Ebrahimie, E, Mills, PC & Shipstone, MA 2017, 'In vitro comparison of the dermal penetration of three different topical formulations containing lasalocid', Veterinary dermatology, vol. 28, no. 4, pp. 342-374. Open access 1
2017	Lwin, EMP, Gerber, C, Song, Y, Leggett, C, Ritchie, U, Turner, S & Garg, S 2017, 'A new LC-MS/MS bioanalytical method for atenolol in human plasma and milk', Bioanalysis, vol 9, no. 7, pp 517-530. Open access 4 3
2017	Lwin, EMP, Gerber, C, Song, Y, Leggett, C, Ritchie, U, Turner, S & Garg, S 2017, 'A new LC-MS/MS bioanalytical method for perindopril and perindoprilat in human plasma and milk', Analytical and bioanalytical chemistry, vol. 409, no. 26, pp. 6141-6148. 1
2017	Ma, N, Liu, J, He, W, Li, Z, Luan, Y, Song, Y & Garg, S 2017, 'Folic acid-grafted bovine serum albumin decorated graphene oxide: an efficient drug carrier for targeted cancer therapy', Journal of colloid and interface science, vol. 490, pp. 598-607. 9 7
2017	Ogunniyi, AD, Khazandi, M, Stevens, AJ, Sims, SK, Page, SW, Garg, S, Venter, H, Powell, A, White, K, Petrovski, KR, Laven-Law, G, Tótoli, EG, Salgado, HR, Pi, H, Coombs, GW, Shinabarger, DL, Turnidge, JD, Paton, JC, McCluskey, A & Trott, DJ 2017, 'Evaluation of robenidine analog NCL195 as a novel broad-spectrum antibacterial agent', PLoS one, vol. 12, no. 9, article no. e0183457, pp. 1-23. Open access 2
2017	Parikh, A, Kathawala, K, Tan, CC, Garg, S & Zhou, X-F 2017, 'Development of a novel oral delivery system of edaravone for enhancing bioavailability', International journal of pharmaceutics, vol. 515, no 1-2, pp. 490-500. Open access 6 6
2017	Parikh, A, Kathawala, K, Tan, CC, Garg, S & Zhou, XF 2017, 'Lipid-based nanosystem of edaravone: development, optimization, characterization and in vitro/in vivo evaluation', Drug delivery, vol. 24, no. 1, pp. 962-978. Open access 5 5
2017	Shaikh, M, Zhang, H, Wang, H, Guo, X, Song, Y, Kanwar, JR & Garg, S 2017, 'In vitro and in vivo assessment of docetaxel formulation developed for esophageal stents', AAPS PharmSciTech, vol. 18, no. 1, pp. 130-137. Open access 3 2
2017	Wang, L, Barclay, T, Song, Y, Joyce, P, Sakala, IG, Petrovsky, N & Garg, S 2017, 'Investigation of the biodistribution, breakdown and excretion of delta inulin adjuvant', Vaccine, vol. 35, pp. 4382-4388.
2017	Zhang, B, Song, Y, Wang, T, Yang, S, Zhang, J, Liu, Y, Zhang, N & Garg, S 2017, 'Efficient co-delivery of immiscible hydrophilic/hydrophobic chemotherapeutics by lipid emulsions for improved treatment of cancer', International Journal of Nanomedicine, vol. 12, pp. 2871-2886. Open access 1 1
2017	Zhang, Q, Song, Y, Page, SW & Garg, S 2017, 'Evaluation of transdermal drug permeation as modulated by lipoderm and pluronic lecithin organogel', Journal of pharmaceutical sciences, vol. 107, no. 2, pp. 587-594. 2 1
2016	Garg, S, Wang, W, Song, Y, Eats, P, Trott, DJ, Page, SW & Petrovski, KR 2016, 'Development of intramammary drug delivery systems: novel in vitro release method', Journal of pharmaceutical sciences, vol. 106, no. 3, pp. 866-871. 1 1
2016	Li, N, Huang, C, Luan, Y, Song, A, Song, Y & Garg, S 2016, 'Active targeting co-delivery system based on pH-sensitive methoxy-poly(ethylene glycol)2K-poly(Îµ-caprolactone)4K-poly(glutamic acid)1K for enhanced cancer therapy', Journal of Colloid and Interface Science, vol. 472, pp. 90-98. Open access 15 15
2016	Narayan, R, Singh, M, Ranjan, O, Nayak, Y, Garg, S, Shavi, G V & Nayak, UY 2016, 'Development of risperidone liposomes for brain targeting through intranasal route', Life sciences, vol. 163, pp. 38-45. Open access 11 9
2016	Shaikh, M, Choudhury, NR, Knott, R, Kanwar, JR & Garg, S 2016, 'Effect of polymer microstructure on the docetaxel release and stability of polyurethane formulation', European Journal of Pharmaceutics and Biopharmaceutics, vol. 101, pp. 82-89. Open access 1 1
2016	Song, Y, Peressin, K, Wong, PY, Page, SW & Garg, S 2016, 'Key considerations in designing oral drug delivery systems for dogs', Journal of Pharmaceutical Sciences, vol. 105, no. 5, pp 1576-1585. Open access 1
2016	Uppalapati, D, Boyd, BJ, Garg, S, Travas-Sejdic, J & Svirskis, D 2016, 'Conducting polymers with defined micro- or nanostructures for drug delivery', Biomaterials, vol. 111, pp. 149-162. 12 12
2016	Zhang, B, Wang, T, Yang, S, Xiao, Y, Song, Y, Zhang, N & Garg, S 2016, 'Development and evaluation of oxaliplatin and irinotecan co-loaded liposomes for enhanced colorectal cancer therapy', Journal of controlled release, vol. 238, pp.10-21. 7 7 2
2016	Zhang, W, Garg, S, Eldi, P, Zhou, FH-h, Johnson, IR, Brooks, DA, Lam, F, Rychkov, G, Hayball, JD & Albrecht, H 2016, 'Targeting prostate cancer cells with genetically engineered polypeptide-based micelles displaying gastrin-releasing peptide', International journal of pharmaceutics, vol. 513, pp.270-279. 9 6 1
2015	Garg, A, Chan, D, Ambados, F, Lwin, E, Song, Y & Garg, S 2015, 'Penicillin stability in prefilled syringes for the purpose of skin testing for drug allergy', Journal of allergy and clinical immunology: in practice, vol. 3, no. 4, pp. 599-601. 1
2015	Kanwar, JR, Roy, K, Patel, Y, Zhou, S-F, Singh, MR, Singh, D, Nasir, M, Sehgal, R, Sehgal, A, Singh, RS, Garg, S & Kanwar, RK 2015, 'Multifunctional iron bound lactoferrin and nanomedicinal approaches to enhance its bioactive functions', Molecules, vol. 20, pp. 9703-9731. Open access 29 22 2
2015	Khazandi, M, Eats, P, Trott, D, Ebrahimie, E, Perry, J, Hickey, E, Page, S, Garg, S & Petrovski, KR 2015, 'Development of an improved Streptococcus uberis experimental mastitis challenge model using different doses and strains in lactating dairy cows', Journal of dairy research, vol. 82, no. 4, pp. 470-477. Open access 2 2
2015	Li, N, Zhang, P, Huang, C, Song, Y, Garg, S & Luan, Y 2015, 'Co-delivery of doxorubicin hydrochloride and verapamil hydrochloride by pH-sensitive polymersomes for the reversal of multidrug resistance', RSC advances, vol. 5, no. 95, pp. 77986-77995. Open access 19 19
2015	Lim, SM, Pang, ZW, Tan, HY, Shaikh, M, Adinarayana, G & Garg, S 2015, 'Enhancement of docetaxel solubility using binary and ternary solid dispersion systems', Drug development and industrial pharmacy, vol. 41, no. 11, pp.1847-1855. 9 7
2015	Shaikh, M, Choudhury, NR, Knott, R & Garg, S 2015, 'Engineering stent based delivery system for esophageal cancer using docetaxel', Molecular Pharmaceutics, vol. 12, no. 7, pp. 2305-2317. 6 5
2015	Simpson, BS, Luo, X, Wang, J, Song, Y, Claudie, DJ, Garg, S, Smith, NM, McKinnon, RA & Semple, SJ 2015, 'Development and evaluation of a topical anti-inflammatory preparation containing Dodonaea polyandra extract', Journal of pharmacy and pharmaceutical science, vol. 18, no. 4, pp. 578-599. Open access
2015	Tótoli, EG, Garg, S & Nunes, SHR 2015, 'Daptomycin: Physicochemical, analytical, and pharmacological properties', Therapeutic Drug Monitoring, vol. 37, no. 6, pp. 699-710. Open access 7 6 4
2015	Wang, W, Song, Y, Petrovski, K, Eats, P, Trott, D, Wong, HS, Page, SW, Perry, J & Garg, S 2015, 'Development of intramammary delivery systems containing lasalocid for the treatment of bovine mastitis: Impact of solubility improvement on safety, efficacy, and milk distribution in dairy cattle', Drug Design, Development and Therapy, vol. 9, pp. 631-642. Open access 11 4
2014	Shaikh, M, Arellano, IH, Choudhury, NR & Garg, S 2014, 'Docetaxel epimerization in silicone films: a case of drug excipient incompatibility', Drug testing and analysis, vol. 6, no. 10, pp. 1076-1084. 3 2
2014	Wahlster, P, Scahill, S, Garg, S & Babar, Z-U-D 2014, 'Identifying stakeholder opinion regarding access to 'high-cost medicines' : a systematic review of the literature', Central European Journal of Medicine, vol. 9, no. 3, pp. 513-527. 2 1 1
2013	Awasthi, A, Razzak, M, Al-Kassas, R, Harvey, J & Garg, S 2013, 'Analytical Profile of Moxidectin', Profiles of drug substances, excipients and related methodology, vol. 38, pp. 315-366. 1 1
2013	Awasthi, A, Razzak, M, Al-Kassas, R, Harvey, J & Garg, S 2013, 'Evaluation of degradation kinetics for abamectin in formulations using a stability indicating method', Acta pharmaceutica, vol. 63, no. 1, pp. 59-69. Open access 1 1
2013	Babar, Z-U-D, Pengelly, K, Scahill, SL, Garg, S & Shaw, J 2013, 'Migrant health in New Zealand: exploring issues concerning medicines access and use', Journal of pharmaceutical health services research, vol. 4, no. 1, pp. 41-49. 8 4 1
2013	Babar, Z-U-D, Scahill, SL, Akhlaq, M & Garg, S 2013, 'A bibliometric review of pharmacy education literature in the context of low- to middle-income countries', Currents in pharmacy teaching and learning, vol. 5, no. 3, pp. 218-232. 10
2013	Chen, S, Cao, Y, Ferguson, LR, Shu, Q & Garg, S 2013, 'Evaluation of mucoadhesive coatings of chitosan and thiolated chitosan for the colonic delivery of microencapsulated probiotic bacteria', Journal of microencapsulation, vol. 30, no. 2, pp. 103-115. 20 18 3
2013	Garg, S, Hasan, R, Scahill, S & Babar, ZU-D 2013, 'Investigating inspection practices of pharmaceutical manufacturing facilities in selected Arab countries: views of inspectors and pharmaceutical industry employees', Eastern mediterranean health journal, vol. 19, no. 11, pp. 919-929. 2 2
2013	Garg, S, Sabri, D, Kanji, J, Rakkar, P, Lee, Y, Naidoo, N & Svirskis, D 2013, 'Evaluation of vitamin D medicines and dietary supplements and the physicochemical analysis of selected formulations', Journal of nutrition, health and aging, vol. 17, no. 2, pp. 158-161. 9 9 14
2013	Gargiulo, D, Chemal, C, Joda, L, Lee, Y, Pilkington, M, Haywood, A & Garg, S 2013, 'Extemporaneous compounding in veterinary practice: a New Zealand perspective', New Zealand veterinary journal, vol. 61, no. 6, pp. 311-315. 3 3
2013	Gorajana, A, Ying, CC, Shuang, Y, Fong, P, Tan, Z, Gupta, J, Talekar, M, Sharma, M & Garg, S 2013, 'Development of solid dispersion systems of dapivirine to enhance its solubility', Current drug delivery, vol. 10, no. 3, pp. 309-316. 7 7
2013	Grey, A, Garg, S, Dray, M, Purvis, L, Horne, A, Callon, K, Gamble, G, Bolland, M, Reid, IR & Cundy, T 2013, 'Low-dose fluoride in postmenopausal women: A randomized controlled trial', Journal of clinical endocrinology and metabolism, vol. 98, no. 6, pp. 2301-2307. Open access 10 9 6
2013	Jin, Y, Wen, J, Garg, S, Liu, D, Zhou, Y, Teng, L & Zhang, W 2013, 'Development of a novel niosomal system for oral delivery of Ginkgo biloba extract', International journal of nanomedicine, vol. 8, pp. 421-430. Open access 24 20 1
2013	Koh, P, Chuah, J, Talekar, M, Gorajana, A & Garg, S 2013, 'Formulation development and dissolution rate enhancement of efavirenz by solid dispersion systems', Indian journal of pharmaceutical sciences, vol. 75, no. 3, pp. 291-301. 24 20 1
2013	Lockhart, MM, Babar, Z-U-D, Carswell, C & Garg, S 2013, 'New Zealand's Drug Development Industry', International journal of environmental research and public health, vol. 10, no. 9, pp. 4339-4351. Open access 1 1
2013	Shaikh, M, Kichenadasse, G, Choudhury, NR, Butler, R & Garg, S 2013, 'Non-vascular drug eluting stents as localized controlled drug delivery platform : preclinical and clinical experience', Journal of controlled release, vol. 172, no. 1, pp. 105-117. 20 17 3
2013	Sharma, M, Waterhouse, GI, Loader, SW, Garg, S & Svirskis, D 2013, 'High surface area polypyrrole scaffolds for tunable drug delivery', International journal of pharmaceutics, vol. 443, no. 1, pp. 163-168. 54 52
2013	Svirskis, D, Sharma, M, Yu, Y & Garg, S 2013, 'Electrically switchable polypyrrole film for the tunable release of progesterone', Therapeutic delivery, vol. 4, no. 3, pp. 307-313. 16
2013	Talekar, M, Ganta, S, Amiji, M, Jamieson, S, Kendall, J, Denny, WA & Garg, S 2013, 'Development of PIK-75 nanosuspension formulation with enhanced delivery efficiency and cytotoxicity for targeted anti-cancer therapy', International journal of pharmaceutics, vol. 450 no. 1, pp. 278-289. 13 14 6
2013	Ye, J, Zhang, W-y, Meng, Q-f, Li, D-h, Garg, S, Teng, L-r & Wen, J-y 2013, 'Forced degradation of flavonol glycosides extracted from Ginkgo biloba', Chemical research in Chinese universities, vol. 29, no. 4, pp. 667-670. 2 1
2012	Awasthi, A, Razzak, M, Al-Kassas, R, Greenwood, D, Harvey, J & Garg, S 2012, 'Isolation and characterization of degradation products of moxidectin using LC, LTQ FT-MS, H/D exchange and NMR', Analytical and bioanalytical chemistry, vol. 404, no. 8, pp. 2203-2222. 12 10
2012	Awasthi, A, Razzak, M, Al-Kassas, R, Greenwood, DR, Harvey, J & Garg, S 2012, 'Separation and identification of degradation products in abamectin formulation using LC, LTQ FT-MS, H/D exchange and NMR', Current pharmaceutical analysis, vol. 8, no. 4, pp. 415-430. 2 1
2012	Awasthi, A, Razzak, M, Al-Kassas, R, Greenwood, DR, Harvey, J & Garg, S 2012, 'Separation and identification of degradation products in eprinomectin formulation using LC, LTQ FT-MS, H/D exchange, and NMR', Journal of pharmaceutical and biomedical analysis, vol. 63, pp. 62-73. 9 9
2012	Awasthi, A, Razzak, M, Al-Kassas, R, Harvey, J & Garg, S 2012, 'An overview on chemical derivatization and stability aspects of selected avermectin derivatives', Chemical and Pharmaceutical Bulletin, vol. 60, no. 8, pp. 931-944. Open access 13 12
2012	Chen, S, Cao, Y, Ferguson, L, Shu, Q & Garg, S 2012, 'The effect of immobilization of probiotic Lactobacillus reuteri DPC16 in sub-100 um microcaspsule on food-borne pathogens', World journal of microbiology and biotechnology, vol. 28, no. 6, pp. 2447-2452. 2 3
2012	Chen, S, Cao, Y, Ferguson, LR, Shu, Q & Garg, S 2012, 'Flow cytometric assessment of the protectants for enhanced in vitro survival of probiotic lactic acid bacteria through simulated human gastro-intestinal stresses', Applied microbiology and biotechnology, vol. 95, no. 2, pp. 345-356. 10 11
2012	Chen, S, Zhao, Q, Ferguson, LR, Shu, Q, Weir, I & Garg, S 2012, 'Development of a novel probiotic delivery system based on microencapsulation with protectants', Applied microbiology and biotechnology, vol. 93, no. 4, pp. 1447-1457. 19 18
2012	Garg, S, Kauffmann, K, Othman, A, Ticehurst, R, Sharma, M & Svirskis, D 2012, 'Stability assessment of extemporaneous formulation of amoxicillin for parenteral antimicrobial therapy', Current Pharmaceutical Analysis, vol. 8, no. 4, pp. 375-380. 1 1
2012	Lockhart, MM, Babar, Z-U-D & Garg, S 2012, 'Drug development and research in New Zealand: policies affecting the industry', Drug development research, vol. 73, no. 1, pp. 1-10. 1 1
2012	Lockhart, MM, Babar, Z-U-D & Garg, S 2012, 'Drug development in NZ: can a country be a cluster?', Drug development research, vol. 73, no. 1, pp. 51-58.
2012	Rajinikanth, P, Keat, NW & Garg, S 2012, 'Self-nanoemulsifying drug delivery systems of Valsartan : preparation and in-vitro characterization', International journal of drug delivery, vol. 4, no. 2, pp. 153-163. Open access 4
2012	Talekar, M, Ganta, S, Singh, A, Amiji, M, Kendall, J, Denny, WA & Garg, S 2012, 'Phosphatidylinositol 3-kinase inhibitor (PIK75) containing surface functionalized nanoemulsion for enhanced drug delivery, cytotoxicity and pro-apoptotic activity in ovarian cancer cells', Pharmaceutical Research, vol. 29, no. 10, pp. 2874-2886. 12 9
2012	Talekar, M, Kendall, J, Denny, W, Jamieson, S & Garg, S 2012, 'Development and evaluation of PIK75 nanosuspension, a phosphatidylinositol- 3-kinase inhibitor', European journal of pharmaceutical sciences, vol. 47, no. 5, pp. 824-833. 15 15
2011	Cazedey, E, Othman, A, Garg, S & Salgado, H 2011, 'A Validated Stability-Indicating LC Method for Orbifloxacin in the Presence of Degradation Products', Current pharmaceutical analysis, vol. 7, no. 3, pp. 176-181. 5 3
2011	Chen, S, Ferguson, LR, Shu, Q & Garg, S 2011, 'The application of flow cytometry to the characterisation of a probiotic strain Lactobacillus reuteri DPC16 and the evaluation of sugar preservatives for its lyophilization', LWT- food science and technology, vol. 44, no. 9, pp. 1873-1879. 4 6
2011	Garg, A, Garg, S & She, R 2011, 'Development of an extemporaneous oral liquid formulation of oxandrolone and its stability evaluation', Burns, vol. 37, no. 7, pp. 1150-1153. 4 1 1
2011	Gupta, J, Othman, A, Tao, JQ & Garg, S 2011, 'Development and validation of a HPLC method for simultaneous determination of Dapivirine and DS003 in combination Microbicide tablet', Current pharmaceutical analysis, vol. 7, no. 1, pp. 21-26. 6 6
2011	Lockhart, MM, Babar, Z-U-D & Garg, S 2011, 'Clinical trials in New Zealand: progress, people, and policies', Drug development research, vol. 72, no. 4, pp. 299-304. 3 1 3
2011	Lyn, L, Sze, H, Rajendran, A, Adinarayana, G, Dua, KK & Garg, S 2011, 'Crystal modifications and dissolution rate of piroxicam', Acta pharmaceutica, vol. 61, no. 4, pp. 391-402. Open access 11 10
2011	Sharma, P, Zujovic, ZD, Bowmaker, G, Denny, WA & Garg, S 2011, 'Evaluation of a crystalline nanosuspension: polymorphism, process induced transformation and in vivo studies', International journal of pharmaceutics, vol. 408, no. 1-2, pp. 138-151. 27 28
2011	Svirskis, D, Travas-Sejdic, J & Garg, S 2011, 'A stability indicating HPLC method for the determination of electrochemically controlled release of risperidone', Journal of chromatographic science, vol. 49, no. 10, pp. 780-785. 7 7
2011	Svirskis, D, Wright, BE, Travas-Sejdic, J & Garg, S 2011, 'Intrinsically conducting polymer platforms for electrochemically controlled drug delivery', in (eds);M Zilberman (ed.), Active implants and scaffolds for tissue regeneration, Springer, Berlin Heidelberg, pp. 481-512. 1
2011	Talekar, M, Kendall, J, Denny, W & Garg, S 2011, 'Targeting of nanoparticles in cancer : drug delivery and diagnostics', Anti-Cancer Drugs, vol. 22, no. 10, pp. 949-962. 64 64 1
2010	Ganta, S, Sharma, P, Paxton, JW, Baguley, BC & Garg, S 2010, 'Pharmacokinetics and pharmacodynamics of chlorambucil delivered in long-circulating nanoemulsion', Journal of Drug Targeting, vol. 18, no. 2, pp. 125-133. 17 16
2010	Garg, S, Goldman, D, Krumme, M, Rohan, L, Smoot, S & Friend, D 2010, 'Advances in development, scale-up and manufacturing of microbicide gels, films, and tablets', Antiviral Research, vol. 88, pp. 519-529. 69 64
2010	Lockhart, MM, Babar, Z-U-D & Garg, S 2010, 'Evaluation of policies to support drug development in New Zealand', Health Policy, vol. 96, no. 2, pp. 108-117. 6 5
2010	Lockhart, MM, Babar, Z-U-D & Garg, S 2010, 'New Zealand's drug development industry - Strengths and opportunities', New Zealand Medical Journal, vol. 123, no. 1314, pp. 52-58. 1
2010	Sharma, P & Garg, S 2010, 'Pure drug and polymer based nanotechnologies for the improved solubility, stability, bioavailability and targeting of anti-HIV drugs', Advanced Drug Delivery Reviews, vol. 62, no. 4-5, pp. 491-502. 99 89 3
2010	Svirskis, D, Travas-Sejdic, J, Rodgers, A & Garg, S 2010, 'Electrochemically controlled drug delivery based on intrinsically conducting polymers', Journal of Controlled Release, vol. 146, no. 1, pp. 6-15. 220 209
2010	Svirskis, D, Wright, B, Travas-Sejdic, J, Rodgers, A & Garg, S 2010, 'Development of a controlled release system for risperidone using polypyrrole: Mechanistic studies ', Electroanalysis, vol. 22, no. 4, pp. 439-444. 32 33
2010	Svirskis, D, Wright, B, Travas-Sejdic, J, Rodgers, A & Garg, S 2010, 'Evaluation of physical properties and performance over time of an actuating polypyrrole based drug delivery system ', Sensors and Actuators B: Chemical: International Journal Devoted to Research and Dev, vol. 151, no. 1, pp. 97-102. 23 24
2009	Ganta, S, Paxton, JW, Baguley, BC & Garg, S 2009, 'Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery', International Journal of Pharmaceutics, vol. 367, no. 1-2, pp. 179-186. 73 67
2009	Garg, S, Svirskis, D, Al-Kabban, M, Farhan, S, Komeshi, M, Lee, J, Liu, Q, Naidoo, N & Kairuz, T 2009, 'Chemical stability of extemporaneously compounded omeprazole formulations: A comparison of two methods of compounding', International Journal of Pharmaceutical Compounding, vol. 13, no. 3, pp. 250-253. 2
2009	Salgado, H, Moreno, A & Garg, S 2009, 'LC-DAD determination of fleroxacin in bulk and pharmaceutical dosage forms ', Chromatographia, vol. 69 no. 2, pp. 237-240. 7
2009	Sharma, P, Denny, W & Garg, S 2009, 'Effect of wet milling process on the solid state of indomethacin and simvastatin ', International Journal of Pharmaceutics, vol. 380, no. 1-2, pp. 40-48. 70 58
2009	Sharma, P, Ganta, S, Denny, W & Garg, S 2009, 'Formulation and pharmacokinetics of lipid nanoparticles of a chemically sensitive nitrogen mustard derivative: Chlorambucil', International Journal of Pharmaceutics, vol. 367, no. 1-2, pp. 187-194. 38 32
2008	Bansal, D & Garg, S 2008, 'Probiotics: From functional foods to pharmaceutical products', Current Pharmaceutical Biotechnology, vol. 9, no. 4, pp. 267-287. 15 12 1
2008	Butcher, JC, Garg, S, Kim, D-Y & Sharma, P 2008, 'A modified approach to predict dissolution and absorption of polydisperse powders', Pharmaceutical Research, vol. 25, no. 10, pp. 2309-2311. 5 5
2008	Ganta, S, Devalapally, H, Baguley, BC, Garg, S & Amiji, M 2008, 'Microfluidic preparation of chlorambucil nanoemulsion formulations and evaluation of cytotoxicity and pro-apoptotic activity in tumor cells', Journal of Biomedical Nanotechnology, vol. 4, no. 2, pp. 165-173. 25 34
2008	Ganta, S, Paxton, JW, Baguley, BC & Garg, S 2008, 'Development and validation of bioanalytical method for the determination of asulacrine in plasma by liquid chromatography', Journal of Pharmaceutical and Biomedical Analysis, vol. 46, no. 2, pp. 386-390. 4 4
2008	Ganta, S, Paxton, JW, Baguley, BC & Garg, S 2008, 'Pharmacokinetics and pharmacodynamics of chlorambucil delivered in parenteral emulsion', International Journal of Pharmaceutics, vol. 360, no. 1-2, pp. 115-121. 50 49
2008	Garg, S, Svirskis, D, Myftiu, J, Behayaa, M, Shahin, D, Thrimawithana, TR, Vidicki, A & Kairuz, T 2008, 'Properties of a formulated paediatric phenobarbitone oral liquid', Journal of Pharmacy Practice and Research, vol. 38, no. 1, pp. 28-31.
2008	Romano, J, Malcolm, R, Garg, S, Rohan, L & Kaptur, PE 2008, 'Microbicide delivery: Formulation technologies and strategies', Current Opinion in HIV and AIDS, vol. 3, no. 5, pp. 558-566. 30 26

Conferences

Year	Output
2009	Svirskis, D, Travas-Sejdic, J, Rodgers, A & Garg, S 2009, 'Polypyrrole film as a drug delivery system for the controlled release of risperidone', 4th International Conference on Advanced Materials and Nanotechnology, AIP - American Institute of Physics, pp. 36-39. Open access 5 1
2008	Tse, S, Sobrun-Maharaj, A, Garg, S, Hoque, E & Ratnasabapathy, Y 2008, 'Building healthy communities: north and south', in S Tse et al. (eds), The third international Asian health and wellbeing conference, The University of Auckland, pp. 1-237.

Other outputs

PATENTS

Zhou SF, Parikh A, Garg S. Novel pharmaceutical oral formulation of Edaravone drug. Provisional Chinese Application, filed on March 16. 2016;SPI160526-53.

Page S, Garg S, Keenan M, McCluskey A, Stevens A. Compounds and Methods of Treating Infections. Country applications. 2016;Filed as 2014262129 and 2013901516 Australia; BR112015027704-7 Brazil; 2,910,756 Canada; NP entry of PCT/AU2014/000483 China; 14791590.4 Europe; 3871/KOLNP/2015 India; NP entry of PCT/AU2014/000483 Japan; 713621 New Zealand; 2015150264 Russian Federation; 14/888,306 USA; PCT/AU2014/000483 PCT; .

Page S, Garg S. Methods of treating bacterial infections. Country applications. 2016;Filed as 2014262127 and 2013901517 Australia; BR112015027699-7 Brazil; 2,910,752 Canada; NP entry of PCT/AU2014/000480 China; 14791748.8 Europe; 3870/KOLNP/2015 India; NP entry of PCT/AU2014/000480 Japan; 713615 New Zealand; 2015150263 Russian Federation; 14/888,289 USA; PCT/AU2014/000460 PCT.

Page S, Garg S, Keenan M, McCluskey A, Stevens A. Compounds and Methods of Treating Infections. PCT International Patent Application, Filed on May 01. 2014;PCT/AU2014/000483.

Garg S, Zaneveld L, Anderson RA, Waller DP. Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa. USA Patent 6706276. 2004;Mar 16.

Research

Patents

Details	Registry	Status
A process for the preparation of a rapidly disintegrating bioadhesive pharmaceutical composition Garg, Sanjay; Kaul, Chaman Lal; Kohli, Gunjan; Raghupathi, Kandrapu; Tambwekar, Kastubh; Vermani, Kavita	IN	Granted
Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa Anderson Jr., Robert Anthony; Garg, Sanjay; Waller, Donald Paul; Zaneveld, Lourens Jan Dirk	CA	Granted
Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa Anderson Jr., Robert Anthony; Garg, Sanjay; Waller, Donald Paul; Zaneveld, Lourens Jan Dirk	CN	Granted
Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa Anderson Jr., Robert Anthony; Garg, Sanjay; Waller, Donald Paul; Zaneveld, Lourens Jan Dirk	EP	Filed
Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa Anderson Jr., Robert Anthony; Garg, Sanjay; Waller, Donald Paul; Zaneveld, Lourens Jan Dirk	US	Granted
Compositions and methods for trapping and inactivating pathogenic microbes and spermatozoa Anderson Jr., Robert Anthony; Garg, Sanjay; Waller, Donald Paul; Zaneveld, Lourens Jan Dirk	WO	Filed
Compounds and methods of treating infections Garg, Sanjay; Keenan, Martine; McCluskey, Adam; Page, Stephen; Stevens, Andrew	CA	Filed
Compounds and methods of treating infections Garg, Sanjay; Keenan, Martine; McCluskey, Adam; Page, Stephen; Stevens, Andrew	EP	Filed
Compounds and methods of treating infections Garg, Sanjay; Keenan, Martine; McCluskey, Adam; Page, Stephen; Stevens, Andrew	US	Filed
Compounds and methods of treating infections Garg, Sanjay; Keenan, Martine; McCluskey, Adam; Page, Stephen; Stevens, Andrew	WO	Filed
Edaravone dosage form Garg, Sanjay; Parikh, Ankit; Zhou, Xinfu	CN	Filed
Edaravone dosage form Garg, Sanjay; Parikh, Ankit; Zhou, Xinfu	WO	Filed
Methods for treating bacterial infections Garg, Sanjay; Page, Stephen	US	Granted
Methods of treating microbial infections, including Mastitis Garg, Sanjay; Page, Stephen	CA	Filed
Methods of treating microbial infections, including Mastitis Garg, Sanjay; Page, Stephen	EP	Filed
Methods of treating microbial infections, including Mastitis Garg, Sanjay; Page, Stephen	US	Filed
Methods of treating microbial infections, including Mastitis Garg, Sanjay; Page, Stephen	WO	Filed
Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient Garg, Sanjay; Kaul, Chaman Lal; Verma, Rajan Kumar	EP	Filed
Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient Garg, Sanjay; Kaul, Chaman Lal; Verma, Rajan Kumar	KR	Granted
Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient Garg, Sanjay; Kaul, Chaman Lal; Verma, Rajan Kumar	US	Filed
Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient Garg, Sanjay; Kaul, Chaman Lal; Verma, Rajan Kumar	WO	Filed
Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient Garg, Sanjay; Kaul, Chaman Lal; Verma, Rajan Kumar	ZA	Filed

External engagement & recognition

Collaborations

External engagement & recognition

Collaborations

Organisation	Country
Ancare Scientific Ltd	NEW ZEALAND
Asure Quality	NEW ZEALAND
Auckland City Hospital	NEW ZEALAND
Australian Nuclear Science and Technology Organisation	AUSTRALIA
Bioactives Research New Zealand	NEW ZEALAND
Changchun University	CHINA
Chuulangun Aboriginal Corporation	AUSTRALIA
CONRAD	UNITED STATES
Deakin University	AUSTRALIA
Dermatology for Animals	AUSTRALIA
DPT Laboratories	UNITED STATES
Flinders University	AUSTRALIA
Gomal University	PAKISTAN
Government Medical College & Hospital	INDIA
Griffith University	AUSTRALIA
Indian Institute of Science Bangalore	INDIA
International Medical University	MALAYSIA
International Partnership for Microbicides	UNITED STATES
Jilin University	CHINA
LTS Lohmann Therapie Systeme	UNITED STATES
Luoda Pharma Pty Ltd	AUSTRALIA
Magee Womens Research Institute	UNITED STATES
Manipal Academy Of Higher Education	INDIA
Manipal College of Pharmaceutical Sciences	INDIA
Manipal University	INDIA
Micromyx	UNITED STATES
Middlemore Hospital - National Burn Centre	NEW ZEALAND
Monash University	AUSTRALIA
Murdoch University	AUSTRALIA
National Institute of Pharmaceutical Education and Research (NISER)	INDIA
Nemucore Medical Innovations, Inc	UNITED STATES
Neoculi Pty Ltd	AUSTRALIA
Northeastern University (China)	CHINA
Pandit Ravishankar Shukla University	INDIA
Postgraduate Institute of Medical Education and Research	INDIA
Punjabi University	INDIA
Royal Perth Hospital	AUSTRALIA
Sao Paulo State University	BRAZIL
Schrödinger	AUSTRIA
Seoul National University	KOREA, REPUBLIC OF
Shandong University	CHINA
Shanghai Jiao Tong University	CHINA
Springer Healthcare	NEW ZEALAND
Thapar University	INDIA
Tianjin University	CHINA
Tianjin University of Science and Technology	CHINA
Tsinghua University	CHINA
Universidade Estadual Paulista	BRAZIL
University of Adelaide	AUSTRALIA
University of Auckland	NEW ZEALAND
University of Canberra	AUSTRALIA
University of Canterbury	NEW ZEALAND
University of Huddersfield	UNITED KINGDOM
University of London	UNITED KINGDOM
University of Manchester	UNITED KINGDOM
University of Melbourne	AUSTRALIA
University of Newcastle	AUSTRALIA
University of Notre Dame United States	UNITED STATES
University of Otago	NEW ZEALAND
University of Queensland	AUSTRALIA
University of Sao Paulo	BRAZIL
University of South Australia	AUSTRALIA
University of South Florida	UNITED STATES
University of Sydney	AUSTRALIA
University of Tasmania	AUSTRALIA
University of Veterinary and Animal Sciences, Lahore	PAKISTAN
University of Waterloo	CANADA
University of Wollongong	AUSTRALIA
Vaxine Pty Ltd	AUSTRALIA
Victoria University of Wellington	NEW ZEALAND
Women's and Children's Hospital	AUSTRALIA
Wuhan University	CHINA
Xian University of Architecture and Technology	CHINA
Xuanwu Hospital Capital Medical University	CHINA
Yangtze Optical Fibre and Cable Joint Stock Limited Company	HONG KONG
Zhejiang Agricultural and Forestry University	CHINA
Zhengzhou University	CHINA

External engagement & recognition

Engagement/recognition	Year
Associate Editor Bioanalysis	2018
Associate Editor Journal of Basic and Applied Pharmaceutical Sciences	2018
Editor Pharmaceutics, BioMed Research International	2018
Editorial Board Member Drug Design Development and Therapy	2018
Editorial Board Member Pharmaceutical Technology, North America	2018
Fellow Indian Pharmaceutical Association (IPA), India	2018
Member Project Management Institute, USA	2018
Regional Editor Oceania Current Pharmaceutical Analysis	2018
Scientific Advisory Committee Member Australasian Pharmaceutical Sciences Association (APSA)	2018
Adjunct International Medical University (IMU), Malaysia	2017
Adjunct Manipal University, India	2017
Associate Editor Bioanalysis	2017
Associate Editor Journal of Basic and Applied Pharmaceutical Sciences	2017
Co-Director China-Australia Centre for Health Science Research (CACHSR)	2017
Editor Pharmaceutics, BioMed Research International	2017
Editorial Board Member Drug Design Development and Therapy	2017
Editorial Board Member Pharmaceutical Technology, North America	2017
Fellow Indian Pharmaceutical Association (IPA), India	2017
Member Project Management Institute, USA	2017
Regional Editor Oceania Current Pharmaceutical Analysis	2017
Scientific Advisory Committee Member Australasian Pharmaceutical Sciences Association (APSA)	2017
Australasian Pharmaceutical Science Association Medal Australasian Pharmaceutical Science Association	2015
Director, Board Member and Chair, Students Affairs Committee International Society of Pharmaceutical Engineering (ISPE), Australasia	2014
Executive Committee Member Australasian Pharmaceutical Sciences Association (APSA)	2014
Director, Board Member and Chair, Students Affairs Committee International Society of Pharmaceutical Engineering (ISPE), Australasia	2013
Executive Committee Member Australasian Pharmaceutical Sciences Association (APSA)	2013
Director, Board Member and Chair, Students Affairs Committee International Society of Pharmaceutical Engineering (ISPE), Australasia	2012
Executive Committee Member Australasian Pharmaceutical Sciences Association (APSA)	2012
Awarded intellectual property rights for the US patent no. US2004009223 US Patent Registry	2011
Director, Board Member and Chair, Students Affairs Committee International Society of Pharmaceutical Engineering (ISPE), Australasia	2011
Executive Committee Member Australasian Pharmaceutical Sciences Association (APSA)	2011
Director, Board Member and Chair, Students Affairs Committee International Society of Pharmaceutical Engineering (ISPE), Australasia	2010
Executive Committee Member Australasian Pharmaceutical Sciences Association (APSA)	2010

Teaching & student supervision

Highlights

Pharmaceutical Science and Technology
Conventional and novel drug delivery systems
Pharmaceutical quality assurance and regulatory affairs
Project management

Teaching & student supervision

Research degree supervision

Supervisions from 2010 shown

Thesis title	Student status
Characterization of nanostructured inulin microparticles as drug delivery vehicle.	Current
Development of a colorectal stent delivery system for anticancer drugs	Current
Development of a localized stent-based drug delivery system for oesophageal cancer	Current
Development of therapeutic treatments to combat burn wound infection	Current
Evaluation of the role of pH in wound healing and development of buffered preparations to promote healing	Current
Novel pH responsive mesoporous nanoparticles for targeting the co-delivery of anticancer agents to multidrug resistant cancer cells	Current
Development of combined therapy for Alzheimer’s disease: a mechanistic study	Completed
Development of localized stent drug delivery system for esophageal cancer	Completed
Development of monocyte targeted delivery system for doxorubicin using modified inulin particles	Completed
Development of novel dosage forms to repurpose the drugs for Alzheimer's disease	Completed
Evaluation of drug transfer in human breast milk	Completed
Targeting prostate cancer cells with elastin like peptide based micelles displaying gastrin releasing peptide	Completed

Professor Sanjay Garg

Alternative contact

Alternative contact details

About me

About me

School of Pharmacy and Medical Sciences

Other UniSA associations

About me

Professional Associations

Experience

Qualifications

Work history

Research

Research themes

Research focus

Highlights

Projects

Outputs

Highlights

Books

Chapters

Journal Articles

Conferences

Other outputs

Current research & highlights

Patents

External engagement & recognition

Collaborations

Collaborations

External engagement & recognition

Associate Editor

Associate Editor

Editor

Editorial Board Member

Editorial Board Member

Fellow

Member

Regional Editor Oceania

Scientific Advisory Committee Member

Adjunct

Adjunct

Associate Editor

Associate Editor

Co-Director

Editor

Editorial Board Member

Editorial Board Member

Fellow

Member

Regional Editor Oceania

Scientific Advisory Committee Member

Australasian Pharmaceutical Science Association Medal

Director, Board Member and Chair, Students Affairs Committee

Executive Committee Member

Director, Board Member and Chair, Students Affairs Committee

Executive Committee Member

Director, Board Member and Chair, Students Affairs Committee

Executive Committee Member

Awarded intellectual property rights for the US patent no. US2004009223

Director, Board Member and Chair, Students Affairs Committee

Executive Committee Member

Director, Board Member and Chair, Students Affairs Committee

Executive Committee Member

Teaching & student supervision

Highlights

Courses and programs

Courses I teach and/or co-ordinate

Research degree supervision

Gallery